Read More

Standard BioTools And SomaLogic To Combine In All-Stock Merger Creating A Diversified Leader In Life Sciences Tools; Standard BioTools Shareholders Will Own ~43% Of The Combined Co, And SomaLogic Shareholders Will Own ~57% Of The Combined Co

Activates Standard BioTools' strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to

LAB